Alpha 2.0
Login Register
» Authors » Nitsan Maharshak

Nitsan Maharshak

Explore the profile of Nitsan Maharshak including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 101
Citations 3190
Followers 0
Related Specialties
Gastroenterology
General Medicine
Microbiology
Top 10 Co-Authors
Iris Dotan
Henit Yanai
Nathaniel Aviv Cohen
Yulia Ron
Ayal Hirsch
Uri Kopylov
Ariella Bar-Gil Shitrit
Eran Zittan
Scott E Plevy
Rami Eliakim
Published In
Inflamm Bowel Dis
J Crohns Colitis
J Clin Med
Clin Gastroenterol Hepatol
Gut Microbes
Affiliations
Soon will be listed here.
Recent Articles
1.
Evolution of Extraintestinal Manifestations in Patients With Ulcerative Colitis Post-Restorative Proctocolectomy and Ileal Pouch-Anal Anastomosis: A Single-Center Retrospective Study
Barenboim A, Weiss T, Argyriou O, Cohen N, Kariv Y, Zemel M, et al.
Inflamm Bowel Dis . 2025 Mar; PMID: 40056429
Background And Aims: Extraintestinal manifestations (EIMs) are common in patients with ulcerative colitis (UC). However, the prevalence and associated factors of EIMs in UC patients post-restorative proctocolectomy with ileal pouch-anal...
2.
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference
Lopetuso L, Deleu S, Puca P, Abreu M, Armuzzi A, Barbara G, et al.
Inflamm Bowel Dis . 2025 Feb; PMID: 39932857
Background: Fecal microbiota transplantation (FMT) is emerging as a potential treatment modality for individuals living with inflammatory bowel disease (IBD). Despite its promise, the effectiveness of FMT for treating IBD,...
3.
Metagenome-informed metaproteomics of the human gut microbiome, host, and dietary exposome uncovers signatures of health and inflammatory bowel disease
Valdes-Mas R, Leshem A, Zheng D, Cohen Y, Kern L, Zmora N, et al.
Cell . 2025 Jan; 188(4):1062-1083.e36. PMID: 39837331
Host-microbiome-dietary interactions play crucial roles in regulating human health, yet their direct functional assessment remains challenging. We adopted metagenome-informed metaproteomics (MIM), in mice and humans, to non-invasively explore species-level microbiome-host...
4.
Ultra-Processed Foods Consumption Is Positively Associated with the Clinical Activity of Inflammatory Bowel Diseases: A Cross-Sectional Single-Center Study
Sarbagili-Shabat C, Zelber-Sagi S, Fliss Isakov N, Hirsch A, Ron Y, Grinshpan L, et al.
Inflamm Intest Dis . 2024 Oct; 9(1):241-251. PMID: 39474331
Introduction: Western diet pattern and its food components have been suggested to impact inflammatory bowel diseases (IBDs) clinical course. However, the importance of food processing level is uncertain. We aimed...
5.
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real-Life Retrospective Multicentre Cohort Study
Bacsur P, Shaham D, Serclova Z, Resal T, Farkas B, Sarlos P, et al.
Aliment Pharmacol Ther . 2024 Oct; 61(2):335-345. PMID: 39468719
Background: Perianal fistulas of Crohn's disease (CD) create a significant burden on patients' lives. However, the efficacy and safety of adipose-derived mesenchymal stem cell treatment are contradicting, and real-world evidence...
6.
Pro-motility Preparation Protocol May Reduce the Rates of Failed Patency Capsule Among Patients with Crohn's Disease in Clinical Remission
Ukashi O, Dotan A, Borkovsky T, Talan Asher A, Thurm T, Hirsch A, et al.
Dig Dis Sci . 2024 Oct; 69(11):4178-4186. PMID: 39384710
Background: Patency capsule (PC) ingestion is commonly used to minimize capsule retention in high-risk patients with Crohn's disease (CD). However, false-positive rates remain high, precluding the use of video capsule...
7.
Pulmonary Manifestations of IBD: Case Report and Review of the Literature
Herling A, Perluk T, Freund O, Maharshak N, Cohen N
J Clin Med . 2024 Sep; 13(18). PMID: 39336887
This article explores the pulmonary complications associated with inflammatory bowel disease (IBD). It presents a detailed case study of a 22-year-old male with Crohn's disease exhibiting pulmonary symptoms. The review...
8.
Deployment of an Artificial Intelligence Histology Tool to Aid Qualitative Assessment of Histopathology Using the Nancy Histopathology Index in Ulcerative Colitis
Rubin D, Kubassova O, Weber C, Adsul S, Freire M, Biedermann L, et al.
Inflamm Bowel Dis . 2024 Sep; PMID: 39284932
Background: Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by increased stool frequency, rectal bleeding, and urgency. To streamline the quantitative assessment of histopathology using the Nancy Index...
9.
Economic and Chronologic Optimization of Fecal Donors Screening Process
Levy B, Fliss Isakov N, Ziv-Baran T, Leshno M, Maharshak N, Werner L
MDM Policy Pract . 2024 Jun; 9(1):23814683241254809. PMID: 38873648
Highlights: What is known:Fecal microbial transplantation (FMT) is the transfer of microbiome from healthy donors to patients.Fecal donors undergo multiple strict screening tests to exclude any transmissible disease.Screening tests of...
10.
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone
Leibovitzh H, Sarbagili Shabat C, Hirsch A, Zittan E, Mentella M, Petito V, et al.
J Crohns Colitis . 2024 May; 18(10):1606-1614. PMID: 38720628
Background And Aims: Several faecal microbial transplantation [FMT] approaches for ulcerative colitis [UC] have been investigated with conflicting results. We have recently published the clinical outcomes from the CRAFT UC...